OXFORDBIODYNAMICS.COM

Home | Oxford Biodynamics

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

http://www.oxfordbiodynamics.com/

OVERVIEW OF oxfordbiodynamics.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR OXFORDBIODYNAMICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 8 reviews

5 star

4

4 star

1

3 star

3

2 star

0

1 star

0

Hey there! Start your review of oxfordbiodynamics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

2.2 seconds

FAVICON PREVIEW

16x16
32x32
64x64

CONTACTS AT OXFORDBIODYNAMICS.COM

Aroul Ramadass

Oxford Bi●●●●●●●●●s Limited

Begbroke Sc●●●●●●●●●●● Sandy Lane

Ya●●on , Oxon, OX5 1PF

United Kingdom

186●●●881

ar●●●●●●●●●●●●@path.ox.ac.uk

View this contact

Aroul Ramadass

Oxford Bi●●●●●●●●●s Limited

Begbroke Sc●●●●●●●●●●● Sandy Lane

Ya●●on , Oxon, OX5 1PF

United Kingdom

186●●●881

ar●●●●●●●●●●●●@path.ox.ac.uk

View this contact

Aroul Ramadass

Oxford Bi●●●●●●●●●s Limited

Begbroke Sc●●●●●●●●●●● Sandy Lane

Ya●●on , Oxon, OX5 1PF

United Kingdom

186●●●881

ar●●●●●●●●●●●●@path.ox.ac.uk

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2007 April 27
UPDATED: 2012 November 26
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

18

YEARS
5

MONTHS
20

DAYS

NAME SERVERS

1: ns17.domaincontrol.com
2: ns18.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

1

SITE IP

35.189.73.106

LOAD TIME

2.172 sec

SCORE

6.2

PAGE TITLE

Home | Oxford Biodynamics | oxfordbiodynamics.com Reviews

<META> DESCRIPTION

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

<META> KEYWORDS

1 applications

2 indications

3 business

4 technology

5 investors

6 investors overview

7 results and presentations

8 share price information

9 regulatory news

10 key corporate documents

CONTENT

Page content here

KEYWORDS ON PAGE

applications,indications,business,technology,investors,investors overview,results and presentations,share price information,regulatory news,key corporate documents,aim rule 26,email alerts,investor contacts,news,about us,history,board of directors,values

SERVER

nginx

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | Oxford Biodynamics | oxfordbiodynamics.com Reviews

https://oxfordbiodynamics.com

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

INTERNAL PAGES

oxfordbiodynamics.com

1

Diagnostics | Oxford Biodynamics

https://www.oxfordbiodynamics.com/applications/early-diagnostics

With the proportion of new cancer cases diagnosed increasing, more effort and new strategies need to be applied to early diagnostics. There is a great deal of evidence to show that early diagnosis is an important factor for surviving cancer. However, an accurate and cost-effective detection of early tumours is still lacking, and the development of screening programmes and organised early diagnostics is highly desirable. 2002-2016 Oxford Biodynamics Limited. Regulated and Licensed by Human Tissue Authority.

2

Oncology | Oxford Biodynamics

https://www.oxfordbiodynamics.com/indications/cancer

With 1 in 3 people being affected by cancer at some point in their life, cancer research has become an important focus of many academic and commercial researchers. These efforts have contributed to great discoveries in the field, saving or extending the lives of many cancer sufferers. OBD is currently producing tests for the following types of cancer:. 2002-2016 Oxford Biodynamics Limited. Regulated and Licensed by Human Tissue Authority. License No. 12571.

3

Prognostic Biomarkers | Oxford Biodynamics

https://www.oxfordbiodynamics.com/applications/prognostic-biomarkers

Prognostic biomarkers are measured before treatment to indicate long-term outcome for patients and give an estimate of the severity and the likely outcome of disease. Upon diagnosis of cancer, determining the correct prognosis is essential for patients in order to manage their disease effectively. The. Biomarker discovery platform provides a non-invasive and rapid test that is uniquely able to identify and stratify aggressive tumours through deregulation of key genes. Oxford BioDynamics offers the. To be...

4

Product Development | Oxford Biodynamics

https://www.oxfordbiodynamics.com/business-debvelopment/product-development

Oxford BioDynamics has developed a biomarker discovery platform, based on the. The Company is developing a network of regional licensees in South-East Asia, Australia, Europe and the USA, to commercialise its technology in different therapeutic areas. The Company is proactively looking at specific diseases and drug treatments where the. Biomarker discovery platform brings immediate solutions to cases of high unmet clinical needs. 2002-2016 Oxford Biodynamics Limited. License No. 12571.

5

Biomarker Discovery&Development | Oxford Biodynamics

https://www.oxfordbiodynamics.com/business-debvelopment/biomarker-discovery-development

Oxford BioDynamics has built a reference facility with an ISO 13485 and ISO 9001 certified fully operational infrastructure. Epigenetic insight and analysis show a significant advantage for the. Read-out on many existing biomarkers, whose value at the level of genetic predisposition, RNA or protein levels of expression are insufficient for successful commercialisation. Discovery platform (NGS and PCR) in combination with the. Assay, discovery to validation of. 2002-2016 Oxford Biodynamics Limited.

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

osem.ox.ac.uk

Oxford Spin-out Equity Management: Portfolio

http://www.osem.ox.ac.uk/portfolio/index.html

Pharma tools and services. Industrial applications / cleantech. Other technology (inc. software). The portfolio currently consists of 84 companies. Four of these are listed on AIM, one on LSE and two on NASDAQ, the others are displayed by sector. Since 2000 around 5 companies a year have been added to the portfolio. If you would like to learn more about any of the companies in the current portfolio please contact us. Or refer to the linked company website addresses. Novel technology enabling a digital ca...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

1

OTHER SITES

oxfordbingo.co.uk

The Oxford Bingo Club, Whitstable - Home

The Oxford Bingo Club Ltd. 16-18 Oxford Street, Whitstable Kent. To Saturday Evenings from 5:30pm, and Friday and Saturday afternoons from 12:00 noon. More will appear here soon, but for more information please call 01227 272736 during opening times.

oxfordbio.com

Oxford Cancer Biomarkers |

Pioneering biomarker technologies for Cancer therapies. Our biomarkers are used to identify the right patient, the right drug and the right dose. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. Our colorectal cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway. ColoTox – Predicts chemotherapy toxicity – Now Available. March 7, 2018. Oxford developed prognostic assay fo...

oxfordbiobank.org.uk

Oxford BioBank

Why should I take part? What do I need to do to take part? What is it like taking part? What happens after my visit? What makes the Oxford BioBank unique? Consent & Withdrawal. Publications on Google Scholar. The Oxford Biobank investigations focus on research into common diseases like diabetes, obesity and cardiovascular disease. If you have visited the Oxford BioBank and would like to comment on your experiences, please visit our Feedback Page. This website uses cookies to improve your experience. ...

oxfordbiochar.com

Oxford Biochar - Home

Biochar is the carbon rich product obtained by the pyrolysis of biomass (heating under oxygen-deprived conditions). Watch our VIDEO. We are excited to announce new partnerships with Four Seasons Fuel. And the Oxford Charcoal Company. 2016: Oxford Biochar, Coventry University and Garden Organics cooperation on citizen science.

oxfordbioconcepts.com

Oxford Bioconcepts

Consultancy to the International Life Science Sector. M: 44 (0)791 2218335. Registered Address: Cox Hinkins and Co, Charterford House, 75 London Road, Oxford, OX3 9BB. Registered in England, No. 6368031.

oxfordbiodynamics.com

Home | Oxford Biodynamics

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

oxfordbioelectronics.com

Oxford Bioelectronics | Linking technology with physiology |

Linking technology with physiology. Pioneering advances in the emerging field of bioelectronics. Bioelectronics is an exciting new area of medicine which is transforming the way we think about and treat the human body. Advances in this pioneering field are already being tipped to rewrite the medical textbooks. Gregory B. Diette, MD, MHS. Johns Hopkins University School of medicine. Pulmonologist, Intensivist and Epidemiologist for two decades. He is a member of the American Thoracic Society. Lorem ipsum ...

oxfordbiofuels.com

Home - Oxford Biofules

Here at Oxford Biofuels Ltd, We believe in protecting the environment for "our" future generations. We recycle waste vegetable oil into carbon neutral environmentally green Biodiesel. All waste from the Biodiesel manufacturing process is sent to a anaerobic digestion plant which uses it to produce Biogas. Biogas can then be combusted to produce heat,electricity or road fuel. The solid waste is then used as fertilizer. All this from a waste product! It JUST makes sense!

oxfordbiomaterials.com

Oxfordbiomaterials Ltd

March 2018: hiring a Research Engineer- See Recruitment page. Silk for the 21st Century. Oxford Biomaterials Ltd - Magdalen Centre, Oxford Science Park, OX4 4GA, Oxford, UK.

oxfordbiomed.com

Oxford Biomedical Research | Assay Kits | Biomarker Assay

Skip to main content. Cortisol The Stress Hormone. Our immunoassay is widely used to measure cortisol in many biological fluids and has been used extensively as a biomarker for stress and to monitor adrenal function. Plasminogen Activation is Involved in Fibrinolysis, Cell Adhesion, Apoptosis, and Cell Proliferation. We offer a complete line of plasminogen activators, inhibitors, enzymes, antibodies, and assay kits. The Glutathione S-transferases: A Large Family of Enzymes with Many Roles. CypExpress is ...

oxfordbiomedica.co.uk

OxfordBioMedica |

Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.